Estimating the 1978–1990 and Future Spread of Human Immunodeficiency Virus Type 1 in Subgroups of Homosexual Men
Hoover D, Munoz A, Carey V, Chmiel J, Taylor J, Margolick J, Kingsley L, Vermund S. Estimating the 1978–1990 and Future Spread of Human Immunodeficiency Virus Type 1 in Subgroups of Homosexual Men. American Journal Of Epidemiology 1991, 134: 1190-1205. PMID: 1746529, DOI: 10.1093/oxfordjournals.aje.a116022.Peer-Reviewed Original ResearchConceptsSeroconversion ratesHomosexual menHuman immunodeficiency virus type 1 (HIV-1) infectionHuman immunodeficiency virus type 1Virus type 1 infectionImmunodeficiency virus type 1Kaplan-Meier methodHIV-1 infectionType 1 infectionAge 55 yearsHIV-1 epidemicVirus type 1AIDS diagnosisSeroconversionAnnual hazardHematologic variablesAge 55Type 1Survival methodsBisexual menHomosexual populationCohortMenAgeInfectionNational AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
Rosenberg PS, Gail MH, Schrager LK, Vermund SH, Creagh-Kirk T, Andrews EB, Winkelstein W, Marmor M, Des Jarlais DC, Biggar RJ. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 392-401. PMID: 2007974.Peer-Reviewed Original ResearchConceptsIntravenous drug usersAIDS incidence trendsIncidence trendsDrug usersHeterosexual contactSevere immunodeficiencyHeterosexual intravenous drug usersHuman immunodeficiency virus (HIV) infectionFavorable trendTransmission groupImmunodeficiency virus infectionIncidence of AIDSCases of AIDSZidovudine therapyTransfusion recipientsVirus infectionNumber of casesZidovudineNew York CityEarly cessationTherapyAIDSMenGay menSan Francisco